Y Intercept Hong Kong Ltd Buys Shares of 9,837 Chemed Corporation $CHE

Y Intercept Hong Kong Ltd bought a new stake in Chemed Corporation (NYSE:CHE) during the second quarter, Holdings Channel.com reports. The firm bought 9,837 shares of the company’s stock, valued at approximately $4,790,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CHE. GAMMA Investing LLC raised its position in Chemed by 113.4% in the first quarter. GAMMA Investing LLC now owns 271 shares of the company’s stock valued at $167,000 after purchasing an additional 144 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in Chemed by 8.2% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 1,496 shares of the company’s stock valued at $921,000 after purchasing an additional 114 shares during the period. Bessemer Group Inc. raised its holdings in shares of Chemed by 14.2% in the 1st quarter. Bessemer Group Inc. now owns 950 shares of the company’s stock valued at $585,000 after buying an additional 118 shares during the period. Smith Salley Wealth Management raised its holdings in shares of Chemed by 1.0% in the 1st quarter. Smith Salley Wealth Management now owns 17,155 shares of the company’s stock valued at $10,556,000 after buying an additional 167 shares during the period. Finally, Mather Group LLC. raised its holdings in shares of Chemed by 53.3% in the 1st quarter. Mather Group LLC. now owns 161 shares of the company’s stock valued at $99,000 after buying an additional 56 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Analysts Set New Price Targets

CHE has been the topic of several research analyst reports. Royal Bank Of Canada cut their price objective on Chemed from $640.00 to $589.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a report on Saturday, July 5th. Jefferies Financial Group upgraded Chemed from a “hold” rating to a “buy” rating and boosted their price objective for the company from $490.00 to $550.00 in a report on Tuesday, September 2nd. Oppenheimer cut their price objective on Chemed from $650.00 to $580.00 and set an “outperform” rating on the stock in a report on Thursday, July 31st. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Four research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $578.50.

Chemed Price Performance

Shares of NYSE CHE opened at $440.35 on Wednesday. The stock’s 50-day moving average is $448.09 and its two-hundred day moving average is $495.79. Chemed Corporation has a 1-year low of $408.42 and a 1-year high of $623.60. The company has a market cap of $6.42 billion, a price-to-earnings ratio of 22.64, a price-to-earnings-growth ratio of 2.53 and a beta of 0.43.

Chemed (NYSE:CHE) last issued its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). The company had revenue of $624.90 million for the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a return on equity of 25.83% and a net margin of 11.56%.Chemed’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities research analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, August 11th. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. This is an increase from Chemed’s previous quarterly dividend of $0.50. Chemed’s payout ratio is currently 12.34%.

Insiders Place Their Bets

In other Chemed news, Director George J. Walsh III acquired 200 shares of the stock in a transaction dated Monday, August 4th. The stock was acquired at an average cost of $417.10 per share, with a total value of $83,420.00. Following the transaction, the director owned 3,523 shares in the company, valued at $1,469,443.30. The trade was a 6.02% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Patrick P. Grace sold 150 shares of the company’s stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the transaction, the director directly owned 3,397 shares of the company’s stock, valued at approximately $1,574,135.83. This represents a 4.23% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 13,162 shares of company stock valued at $5,677,511. 3.29% of the stock is owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.